Supplemental eTable 2-Sensitivity analysis -fully adjusted Hazard Ratios for heart failure and all-cause mortality by Galectin-3 quartiles at baseline (N=1,809), with and without further adjustment for baseline Cardiovascular Disease status Fully adjusted (Model 2): adjusted for age (years), race-center (whites-Washington County; whites-Minneapolis; blacks-Jackson; blacks-Forsyth County, whites-Forsyth County), sex (male or female), smoking status (current, former, or never), mean systolic blood pressure (mm Hg), mean diabolic blood pressure (mm Hg), anti-hypertensive medication use (yes or no), total cholesterol (mg/dL), HDL-cholesterol (mg/dL), diabetes status (self-reported history, medication use, glucose, HbA1c), and low eGFR (yes or no).
Supplemental eFigure-1. Untransformed and log-transformed distributions of galectin-3, by race status (Kernel density plots).
